NCT06785597View on ClinicalTrials.gov

EpigenOMic Determinants of the Neuroendocrine Phenotype As Biomarkers for Neuroendocrine Neoplasms

RecruitingOBSERVATIONAL
Enrollment

130

Participants

Timeline

Start Date

October 21, 2024

Primary Completion Date

October 21, 2026

Study Completion Date

October 21, 2026

Conditions
Mixed Neuroendocrine-Non Neuroendocrine NeoplasmNeuroendocrine Neoplasm
Trial Locations (1)

20141

RECRUITING

European Institute of Oncology, Milan

All Listed Sponsors
collaborator

Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo

OTHER

lead

European Institute of Oncology

OTHER